US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 6.030
  • -0.260-4.13%
Close Dec 13 16:00 ET
  • 6.060
  • +0.030+0.50%
Post 19:23 ET
127.80MMarket Cap-1.10P/E (TTM)

Enanta Pharmaceuticals Key Stats

Enanta Pharmaceuticals Q4 2024 Earnings Date

Currency:USDNov 25, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
17.83M
14.61M
-3.22M
Miss Est.
-5.83%
-22.84%
-18.07%
EPS
-1.07
-1.36
-0.29
Miss Est.
+19.33%
-2.26%
-26.77%
Buy

Dec 11, 2024

Enanta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 16.422M--
--2025/Q1-- / 17.666M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 16.422M--
--2025/Q1-- / 17.666M--
Nov 25, 20242024/Q414.607M / 17.828M--
Aug 5, 20242024/Q317.971M / 17.156M--
May 6, 20242024/Q217.054M / 16.207M--

Unlock Free Earnings Estimates

Enanta Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 11, 2024

Buy

  • Buy

    57.14%
  • Hold

    28.57%
  • Sell

    14.29%

Price Target

No Data